Epstein Secrets

5,195.00 106,455.00 1/10/11 DB 2.000.000 BANK OF AMERICA 8 1/8% pid STK DEC 29, 2049 2,230,000.00 2,235,000.00 (5,000.00) 4/3/13 DB 300,000 BARCLAYS BANK PLC 7.750% 04/102023 DT 320,250.00 316,875.00 3,375.00 2/14/12 DB 2,095 BIOGEN IDEC INC 609,582.00 511,578.05 98,003.95 7/10/07 DB 20,000 Bom

230,000.00 2,235,000.00 (5,000.00) 4/3/13 DB 300,000 BARCLAYS BANK PLC 7.750% 04/102023 DT 320,250.00 316,875.00 3,375.00 2/14/12 DB 2,095 BIOGEN IDEC INC 609,582.00 511,578.05 98,003.95 7/10/07 DB 20,000 Bomdardier 90,316.00 90,917.74 (601.74) 7/12/10 DB 50,000 Deutsche Bk Ag LDN BRH 395,0

1.00 18.50 0.00 Quantity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss Est. Annual Inc. Accrued Div. Yield Preferred Stocks BARCLAYS BANK PLC 25.54 PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 GMAC CAPITAL TRUST I PFD STK

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

C ACCT. For the Period 8/1/12 to 8/31/12 Price US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG Preferred Stocks BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CAPITAL ONE FINANCIAL CO PFD 6% 14040H-40-2 COF PP CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-2

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP

Mid Cap Equity DEUTSCHE BK AG LDN BRH 8.90 DBL LONG ETN38 25154H-55-8 DAG Preferred Stocks ANNALY CAPITAL MGMT PFD 7 5/8% 035710-70-6 NLY PC BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 26.46 30,000.000 793,800.00 750,00

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

3.17 50,000.000 658,500.00 352,529.00 305,971.00 Emerging Market Equity P GRUPO FIN SANTANDER-ADR B 12.18 40053C-10-5 BSMX Preferred Stocks BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 P CBL & ASSOCIATES PROP PFD 6 5/8% 124830-80-3 CBLA CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973

10-9 GLOG Preferred Stocks P P ALEXANDRIA REAL ESTATE E PFD 6.45% 015271-70-3 ARE PENA /BAA AMERICAN CAPITAL AGENCY 8% PFD 02503X-20-4 AGNC BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20-1 C PNNA /BA1 GMAC CAPITAL TRUST I PFD STK 8 1/8%

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

0 2,184,600.00 2,000,000.00 184,600.00 US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 14.22 DBL LONG ETN38 25154H-55-8 DAG Preferred Stocks BARCLAYS BANK PLC PFD SHS SER 5 8 1/8% 06739H-36-2 BCS PDAA /P-2 P CHESAPEAKE LODGING TRUST PFD 7 3/4% 165240-20-1 CITIGROUP CAPITAL XIII 7 7/8% PFD 173080-20

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

age 14 of 48 Consolidated Statement Page 17 EFTA01546923 SOUTHERN FINANCIAL, LLC ACCT. For the Period 8/1/13 to 8/31/13 Price US Fixed Income BARCLAYS BANK PLC 7.750% 04/10/2023 DTD 04/10/2013 06739F-HK-0 BB+ /NR HOMEBANC MORTGAGE TRUST 2004-1 CL 1M1 VAR RT 08/25/2029 DTD 07/30/2004 43739E-AC-1 CCC /CA

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A GENERAL ELECTRIC CO 04033A-10-0 ARIA 213.02 09062X-10-3 BIIB 41.29 30303M-10-2 FB 23.14 369604-10-3 GE JPM VALUE ADVANTAGE F

% PFD STK DEC 29 2049 DTD 04/30/2008 ASSET TRANSFER TO A/C W92099-0 SOUTHERN FINANCIAL, LLC AS OF 09/25/13 (ID: 060505-DT-8) 9/25 Free Delivery BARCLAYS BANK PLC 7.750% 04/10/2023 DTD 04/10/2013 ASSET TRANSFER TO A/C W92099-0 SOUTHERN FINANCIAL, LLC AS OF 09/25/13 (ID: 06739F-HK-0) 9/25 9/25 9/25 Free D

. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC ASCENA RETAIL GROUP INC 04033A-10-0 ARIA 19.93 COM 04351G-10-1 ASNA BIOGEN IDEC INC FACEBOOK INC-A GENERAL ELECTRIC CO JP MORGAN CHASE & CO JPM VALUE ADVANTAGE FD - INSTL 09062X-10-3 BIIB 50.23 30303M-10-2 FB 23.89 369604-10

age 15 of 33 Consolidated Statement Page 18 EFTA01546806 SOUTHERN FINANCIAL, LLC ACCT. For the Period 7/1/13 to 7/31/13 Price US Fixed Income BARCLAYS BANK PLC 7.750% 04/10/2023 DTD 04/10/2013 06739F-HK-0 BB+ /NR HOMEBANC MORTGAGE TRUST 2004-1 CL 1M1 VAR RT 08/25/2029 DTD 07/30/2004 43739E-AC-1 CCC /CA

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A GENERAL ELECTRIC CO 04033A-10-0 ARIA 218.13 09062X-10-3 BIIB 36.80 30303M-10-2 FB 24.37 369604-10-3 GE JPM VALUE ADVANTAGE F